Focus on Infectious Disease
  • Saved

Will COVID Finally Help US FDA And Sponsors Overcome Their ‘Angst’ On Innovative Trial Designs?

Will COVID Finally Help US FDA And Sponsors Overcome Their ‘Angst’ On Innovative Trial Designs?

Source : 'The Pink Sheet'

The coronavirus pandemic managed to change minds at the US Food and Drug Administration about innovative clinical trial designs, an attitude many hope remains once the public health emergency ends.

Safety...

  • Saved

Memo To File: How US FDA Decided Which Janssen Vaccine Drug Substance Batches Were OK To Use

Memo To File: How US FDA Decided Which Janssen Vaccine Drug Substance Batches Were OK To Use

Source : 'The Pink Sheet'

An internal memorandum the US Food and Drug Administration publicly shared on the day it was written shows how the agency made a potentially controversial decision on COVID-19...

  • Saved

How COVID Boosted Medtech In The Eyes Of The World

How COVID Boosted Medtech In The Eyes Of The World

Source : IN VIVO

The famously fragmented medtech industry acted almost as one and found common ground with health care stakeholders from across the spectrum as never before during the COVID-19 crisis.

Reflecting on how...

  • Saved

Financial Penalties, COVID-19 Liability Top FDLI List Of Top Medtech Lawsuits

Financial Penalties, COVID-19 Liability Top FDLI List Of Top Medtech Lawsuits

Source : Medtech Insight

Cigar manufacturers and payday lenders may not be what you think of when you think of the device industry, but lawsuits focused on those businesses could have ripple effects on...

  • Saved

To RRA, Or Not To RRA? BD Talks Decision-Making Around FDA Requests For Remote Regulatory Assessments

To RRA, Or Not To RRA? BD Talks Decision-Making Around FDA Requests For Remote Regulatory Assessments

Source : Medtech Insight

To RRA, or not to RRA? That’s the question facing many medical device manufacturers that are being approached by the US Food and Drug Administration to participate in a virtual...